Paychex Stock Quote P1AY34 - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Brazil
BOV
Paychex Inc (P1AY34) Quote

Paychex Inc (P1AY34)

327.36

0.00

(0.00%)

Closed June 29 4:55PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

327.36

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

270.81 52 Week Range 327.36

Market Cap

Previous Close

327.36

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

10

Shares Outstanding

360,546,000

Dividend Yield

2.14%

PE Ratio

27.43

Earnings Per Share (EPS)

4.32

Revenue

5.01B

Net Profit

1.56B

Sector

Engineering Services

Industry

Engineering Services

Website

www.paychex.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Paychex Inc is listed in the Engineering Services sector of the Brazil Bovespa Exchange with ticker P1AY34. The last closing price for Paychex was R$327.36. Over the last year, Paychex shares have traded in a share price range of R$ 270.81 to R$ 327.36.

Paychex currently has 360,546,000 shares outstanding. The market capitalization of Paychex is R$42.71 billion. Paychex has a price to earnings ratio (PE ratio) of 27.43.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	327.36	327.36	327.36	10	327.36	DR
12	11.36	3.59493670886	316	327.36	303	10	315.13173913	DR
26	36.56	12.5722145805	290.8	327.36	288.4	6	308.38445255	DR
52	55.93	20.6056810227	271.43	327.36	270.81	12	298.29478049	DR
156	62.16	23.4389140271	265.2	383.49	265.2	89	318.82460941	DR
260	155.71	90.7136615205	171.65	383.49	126.86	110	268.06497174	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ASNSActelis Networks Inc	$ 2.3599 (59.45%)	71.61M
COSMCosmos Health Inc	$ 1.05 (54.64%)	81.3M
LUCYInnovative Eyewear Inc	$ 0.5036 (52.61%)	364.85M
NNENano Nuclear Energy Inc	$ 23.43 (44.45%)	9.41M
NBSTWNewbury Street Acquisition Corporation	$ 0.0613 (39.32%)	19.62k
CINGCingulate Inc	$ 0.3152 (-46.03%)	2.57M
BTOGBit Origin Ltd	$ 2.88 (-45.86%)	3.39M
ACCDAccolade Inc	$ 3.598 (-43.69%)	18.09M
NXLNexalin Technologies Inc	$ 1.71 (-42.23%)	4.51M
APVOAptevo Therapeutics Inc	$ 0.3011 (-41.52%)	2.52M
LUCYInnovative Eyewear Inc	$ 0.507001 (53.64%)	356.92M
NVDANVIDIA Corporation	$ 124.3812 (0.32%)	248.1M
FFIEFaraday Future Intelligent Electric Inc	$ 0.513 (-14.50%)	189.18M
SQQQProShares UltraPro Short QQQ	$ 8.20 (0.86%)	142.65M
TSLATesla Inc	$ 196.72 (-0.35%)	82.53M

JOHNNIEBG

JOHNNIEBG 22 seconds ago

This is great. You are telling us that you believe everything that RB100 says it the absolute truth. Thanks for confirming that. Now we know what you really think.......

exwannabe

exwannabe 40 seconds ago

Yes, having acquired a couple Phase 2 trials is fine...
What trials?

I am sure they do exist, but the failure to enumerate suggests they are dead trials walking. The reason Roswell sold them for chump change.

TRUSTUNITS1000000

TRUSTUNITS1000000 53 seconds ago

TRUSTUNITS1000000

TRUSTUNITS1000000 1 minute ago

Too bad what happened here

fluteman

fluteman 2 minutes ago

Collaborations are in place!!!!!!
Stealth mode on that for now!!
More news coming soon!!!

TRUSTUNITS1000000

TRUSTUNITS1000000 2 minutes ago

People were stealing diamonds

InvestInBiel

InvestInBiel 2 minutes ago

Would YOU like to be CEO?

ison929

ison929 2 minutes ago

Wow ... that speaks volume.

"PURPOSELY REMAINED IN STEALTH MODE!!! She says"

theorysuit

theorysuit 2 minutes ago

oh now lawsuits....you can't make this sht up

the value will come with regulatory approval you idiot! and only EMA or FDA, not UK!

TRUSTUNITS1000000

TRUSTUNITS1000000 2 minutes ago

80 s I knew this company

Troymister

Troymister 3 minutes ago

Yes, having acquired a couple Phase 2 trials is fine...but long-standing shareholders are hoping to hear some payoff is closer...holding our breath as she moves into the "future" part of her under-prepared comments.

TRUSTUNITS1000000

TRUSTUNITS1000000 3 minutes ago

timberwolf7

timberwolf7 3 minutes ago

Too late to replace biden in 4 swing states? Unless he 'dies' or they run the 25th on him.. Hmm IF I
was biden? I would be wondering how fast my time of being a useful idiot was going to end..and
how they are going to do it..

https://www.thegatewaypundit.com/2024/0

satter

satter 3 minutes ago

They don't ignore them. They have reported on the fake reported several times. How many times do they need to report on anti-vaxxers reporting fake sudden deaths linked to vaccines when they were not deaths due to vaccine?

‘Died suddenly’ posts twist tragedies to push vaccine

manibiotech

manibiotech 3 minutes ago

Sure , that will create lot of “Buzz” in market , when a finished trial for half a decade is awaiting application to be submitted to FDA.

TRUSTUNITS1000000

TRUSTUNITS1000000 3 minutes ago

Had diamond a while back

TRUSTUNITS1000000

TRUSTUNITS1000000 3 minutes ago

Would make a great reverse merger

TRUSTUNITS1000000

TRUSTUNITS1000000 4 minutes ago

Not many shares outstanding

NYBob

NYBob 4 minutes ago

WORLD MAGA NEWS - They’ve Lost The Confidence Of The American People’: Byron Donalds Slams Dems For Focus On Jan 6th
Forbes Breaking News
3.2M subscribers

[YT]DiXaJN5FJu4[/YT]

https://www.youtube.com/watch?v=DiXaJN5FJu4

Douglas MacGregor U

DANKRAN GOD GOLD

TRUSTUNITS1000000

TRUSTUNITS1000000 4 minutes ago

Interesting company

theorysuit

theorysuit 4 minutes ago

Dude, Ginormous, Trial master file, ADVENT, Direct, Rosewell.

no one gives AF. What about expected timeline for decision? crickets.

phase 3 for direct and rosewell....let's keep deflecting on these other non important sht.

TRUSTUNITS1000000

TRUSTUNITS1000000 4 minutes ago

Shareholders post

KevGee59

KevGee59 4 minutes ago

Blah...Blah...Blah...Blah...Blah!

fluteman

fluteman 5 minutes ago

DC Direct is back—for inoperable tumors!!
Partnering with other biológics, etc….

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions